|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current Assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Accounts receivable, net of allowances of $14,503 and $18,123 | |||||||||||||||||||
| Inventory | |||||||||||||||||||
| Other current assets | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Deferred tax assets | |||||||||||||||||||
| Total investments in and advances to nonconsolidated affiliate | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and stockholders’ equity | |||||||||||||||||||
| Current Liabilities: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Sales and income taxes payable | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Current portion of long-term debt | |||||||||||||||||||
| Current portion of Related Party payable pursuant to Tax Receivable Agreement | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Long-term debt | |||||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||||
| Related Party payable pursuant to Tax Receivable Agreement | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders’ equity (Notes 1 and 10): | |||||||||||||||||||
| Common stock, $0.001 par value per share; 2,000,000,000 shares authorized, 671,711,593 and 669,076,651 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Preferred stock, $0.001 par value per share; 25,000,000 shares authorized and no shares issued and outstanding | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||||
| Preferred stock, par value (in dollars per share) | |||||||||||||||||||
| Preferred stock, shares authorized (shares) | |||||||||||||||||||
| Preferred stock, shares outstanding (shares) | |||||||||||||||||||
| Preferred stock, shares issued (shares) | |||||||||||||||||||
| Common stock, shares authorized (shares) |
Loading...
